IPA says implementation of Draft Pharmaceutical Policy will complicate the Regulator’s functioning and lead to delays,the emphasis in improving manufacturing quality will increase cost of production and impact competitiveness of the Industry.
You need to log in to upload images from your computer.
Admin has disabled this function.
